QRON Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.07
Previous CloseN/A
Volume60.00
Average Volume (3M)166.00
Market Cap
$198.86K
Enterprise Value$495.14K
Total Cash (Recent Filing)$659.00
Total Debt (Recent Filing)$296.00K
Price to Earnings (P/E)―
Beta-0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding17,914,999
10 Day Avg. Volume500
30 Day Avg. Volume166
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)-5.72
Price to Sales (P/S)0.00
P/FCF Ratio-41.17
Enterprise Value/Market Cap2.49
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda1.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Qrons News
QRON FAQ
What was Qrons Inc.’s price range in the past 12 months?
Qrons Inc. lowest stock price was $0.01 and its highest was $0.07 in the past 12 months.
What is Qrons Inc.’s market cap?
Qrons Inc.’s market cap is $198.86K.
When is Qrons Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qrons Inc.’s earnings last quarter?
Currently, no data Available
Is Qrons Inc. overvalued?
According to Wall Street analysts Qrons Inc.’s price is currently Overvalued.
Does Qrons Inc. pay dividends?
Qrons Inc. does not currently pay dividends.
What is Qrons Inc.’s EPS estimate?
Qrons Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qrons Inc. have?
Qrons Inc. has 17,914,999 shares outstanding.
What happened to Qrons Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qrons Inc.?
Currently, no hedge funds are holding shares in QRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qrons Inc.
Qrons, Inc. is a biotechnology company, which engages in the development of treatments and technologies for neuronal and infectious diseases. Its proprietary patents include Techniques for Promoting Neuronal Recovery, Therapeutic Polypseudorotaxane Hydrogels, and Tellurium Compositions and Techniques for Use Therewith. The company was founded by Jonah Martin Meer and Ido Merfeld on August 22, 2016 and is headquartered in Glendale, CA.
Technical Analysis
Scinai Immunotherapeutics
―
Aditxt
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―
CDT Equity
―

